Final Results of a Multicenter Phase II Trial Assessing the Activity and Efficacy of Helicobacter Pylori-Eradicating Antibiotic Therapy As Exclusive Treatment for Patients with Stage I-III Diffuse Large B-Cell Lymphoma of the Stomach (the HGL-1 Trial)

Govi S;Patti C;Raderer M;Andriani A;Caraciolo D;Guidetti A;Ilariucci F;Luminari S;Mule A;Viale E;Arcidiacono PG;PONZONI , MAURILIO;Ferreri AJM

2011-01-01